Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cureus is a digital health and medical publishing company that operates the Cureus Journal of Medical Science, an open-access, online-only multispecialty medical journal. The company focuses on reducing barriers to publication and dissemination of medical knowledge through a technology-enabled submission, peer-review, and post-publication engagement platform for clinicians, researchers, and patients. Founded in Silicon Valley, Cureus built a low-cost, rapid-turnaround publishing model and community-driven platform spanning more than 60 medical specialties. In December 2022, Cureus was acquired by Springer Nature and now operates as part of Springer Nature's health division. Its business is centered on scholarly publishing services rather than drug development, therapeutics, or clinical-stage biopharma programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cureus.